VP Partners AG is a company that appears to be involved in investment and venture capital services, with a focus on supporting startups and entrepreneurs. The company emphasizes the importance of embracing uncertainty and fostering innovation, as indicated by the interview with Pierrick Poulenas, CEO of Picterra, who discusses the dynamics of startup growth and the qualities to seek in an investor.

Healthcare & Technology Venture Capital since 2001.

Vi Partners is the longest-established Swiss Venture Capital firm. For more than 20 years, Vi Partners has been supporting innovative Technology and Healthcare companies, investing over CHF 330m in 66 startups. Vi Partners-managed funds are backed by Switzerland’s most visible companies and institutions, including ETH Zurich, ABB, Buhler, Credit Suisse, Hilti, McKinsey, Nestlé, Schindler, Sulzer, Suva and ZKB as well as the European Investment Fund and many other institutional investors.

Sequana Medical

Windeln.de

Advanon

Amal Therapeutics

Ganymed Pharmaceuticals

Genkyotex

Delenex Therapeutics

Endosense

Oculis

Kuros Biosciences

Mobileye

Vi Partners

VP Partners AG

CH:VIPARTNERS

VP Partners AG

Analysis Not Available